tiprankstipranks
Trending News
More News >
BioVaxys Technology (TSE:BIOV)
:BIOV
Canadian Market

BioVaxys Technology (BIOV) Financial Statements

Compare
21 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently C$7.29M. The company's EPS TTM is C$-0.031; its P/E ratio is -1.12; BioVaxys Technology is scheduled to report earnings on October 2, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -3.30MC$ -2.40MC$ -4.08MC$ -6.44MC$ -1.10M
EBITDAC$ -3.95MC$ -7.69MC$ 0.00C$ -6.42MC$ -1.09M
Net IncomeC$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17M
Balance Sheet
Cash & Short-Term InvestmentsC$ 211.81KC$ 977.00C$ 141.90KC$ 593.12KC$ 2.42M
Total AssetsC$ 1.30MC$ 113.48KC$ 865.56KC$ 8.50MC$ 10.46M
Total DebtC$ 68.08KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -143.73KC$ -977.00C$ -141.90KC$ -593.12KC$ -2.42M
Total LiabilitiesC$ 3.22MC$ 3.49MC$ 1.64MC$ 326.86KC$ 900.09K
Stockholders' EquityC$ -1.92MC$ -3.37MC$ -773.53KC$ 8.18MC$ 9.56M
Cash Flow
Free Cash FlowC$ -2.92MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Operating Cash FlowC$ -1.86MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Investing Cash FlowC$ -1.06MC$ 0.00C$ 0.00C$ 0.00C$ 61.36K
Financing Cash FlowC$ 3.13MC$ 917.10KC$ 1.11MC$ 3.44MC$ 3.35M
Currency in CAD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS